During the past decade, Tokai University Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 20 clinical trials were completed, i.e. on average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 16 clinical trials were completed. i.e. 76.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokai University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Takeda" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokai University Hospital" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Tokai University Hospital" are "Multiple Myeloma" (5 trials), "Ovarian Cancer" (4 trials), "Psoriasis" (4 trials), "Coronary Artery Disease" (3 trials) and "Fallopian Tube Cancer" (3 trials). Many other conditions were trialed in "Tokai University Hospital" in a lesser frequency.

Most popular intervention types in "Tokai University Hospital" are "Drug" (42 trials), "Device" (8 trials), "Biological" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (3 trials), "Dexamethasone" (3 trials), "parsaclisib" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tokai University Hospital" are 52 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Tokai University Hospital". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Tokai University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Tokai University Hospital, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".